About us
Our company
and people
Camurus at a glance
Camurus is a science-led, global pharmaceutical company focused on developing and commercializing innovative medicines with the potential to significantly improve treatment for patients with severe and chronic diseases within Central Nervous System (CNS) diseases, rare diseases, endocrine disorders, oncology and supportive care.
Camurus has over 250 employees and operations in 12 countries within Europe, Australia and the US, with headquarters in Lund, Sweden. Camurus Inc is located in Princeton, New Jersey, US.
The company’s share is listed on Nasdaq Stockholm under the ticker “CAMX”.
our Commitment
Making a difference
Camurus focuses on developing and commercializing innovative medical products to improving the lives of patients with severe and chronic diseases.
Technology
Combining R&D expertise and leading technology
Camurus uses strong R&D expertise and proprietary FluidCrystal® technology in an effort to develop innovative, long-acting treatments.
Pipeline
Diversified pipeline with significant potential
Camurus’ clinical pipeline includes product candidates being investigated for the potential treatment of substance use disorder, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies.
Responsibility
At Camurus we strive to be recognized for the value we bring to patients and their caregivers, healthcare stakeholders, customers, partners and the community. We strive to be trusted and respected for our approaches to conducting our businesses, including research, development and commercialization of our products.
Camurus US leadership team
Meet Camurus’ US leadership team.
Management team
Meet Camurus’ management team.
Board of directors
Meet Camurus’ board of directors.